ABSTRACT
The number of patients treated for hanseniasis and cancer in Israel is not sufficient for a statistical analysis. A general conclusion about the incidence of cancer in hanseniasis patients has not been reached. The data presented may be perhaps useful for a comparison with those of other researchers interested in the subject.
Subject(s)
Leprosy/complications , Neoplasms/complications , Adult , Aged , Female , Humans , Israel , Leprosy/epidemiology , Male , Middle Aged , Neoplasms/epidemiologyABSTRACT
El numero de enfermos tratados de hanseniasis y cancer, en Israel, no es suficiente para un analisis estadistico. No se llego todavia a una conclusion general sobre la incidencia de cancer en pacientes de hanseniasis. Los elementos presentados en este trabajo pueden ser utiles para una comparacion con aquellos de otros investigadores interesados en el assunto
Subject(s)
Adult , Middle Aged , Humans , Male , Female , Leprosy , NeoplasmsABSTRACT
We present a patient with leprosy who developed Hodgkin's disease of the nodular sclerosing type. There are two previous reports describing the combination of leprosy and Hodgkin's disease in a single patient [3, 9]. Hodgkin's disease was diagnosed 14 months after the complete disappearance of mycobacterium leprae from the skin lesions, under treatment with DDS (diamino-diphenyl-sulfone). Hodgkin's disease was treated by irradiation and chemotherapy. Obstructive jaundice developed which resolved under treatment by irradiation of the hilar area of the liver, chemotherapy and hormones. During two years of immuno-suppressive therapy, without DDS, no exacerbation of the leprosy occurred.